Review
Manufacturing of recombinant therapeutic proteins in microbial systems
Klaus Graumann Dr.,
Andreas Premstaller,
Corresponding Author
Klaus Graumann Dr.
Novartis Biopharmaceutical Operations, Sandoz GmbH, Kundl, Austria
Novartis Biopharmaceutical Operations, Sandoz GmbH, Biochemiestrasse 10, 6250 Kundl, Austria, Fax: +43 (0) 5338 200 461Search for more papers by this authorAndreas Premstaller
Novartis Biopharmaceutical Operations, Sandoz GmbH, Kundl, Austria
Search for more papers by this author
Klaus Graumann Dr.,
Andreas Premstaller,
Corresponding Author
Klaus Graumann Dr.
Novartis Biopharmaceutical Operations, Sandoz GmbH, Kundl, Austria
Novartis Biopharmaceutical Operations, Sandoz GmbH, Biochemiestrasse 10, 6250 Kundl, Austria, Fax: +43 (0) 5338 200 461Search for more papers by this authorAndreas Premstaller
Novartis Biopharmaceutical Operations, Sandoz GmbH, Kundl, Austria
Search for more papers by this authorAbstract
Recombinant therapeutic proteins have gained enormous importance for clinical applications. The first recombinant products have been produced in E. coli more than 20 years ago. Although with the advent of antibody-based therapeutics mammalian expression systems have experienced a major boost, microbial expression systems continue to be widely used in industry. Their intrinsic advantages, such as rapid growth, high yields and ease of manipulation, make them the premier choice for expression of non-glycosylated peptides and proteins. Innovative product classes such as antibody fragments or alternative binding molecules will further expand the use of microbial systems. Even more, novel, engineered production hosts and integrated technology platforms hold enormous potential for future applications. This review summarizes current applications and trends for development, production and analytical characterization of recombinant therapeutic proteins in microbial systems.
REFERENCES
- 1 Walsh, G.: Biopharmaceutical benchmarks – 2003. Nat. Biotechnol., 2003, 21, (8), 865–870.
- 2 Walsh, G., Current status of biopharmaceuticals: Approved products and trends in approvals, in: Knäblein, J. (Ed.) Modern Biopharmaceuticals, Wiley-VCH Verlag Weinheim 2005, pp. 1–34.
- 3 http://www.emea.eu.int
- 4 http://www.fda.gov/cder
- 5 Reichert, J.M., Paquette, C.: Therapeutic recombinant proteins: Trends in US approvals 1982 to 2002. Curr. Opin. Mol. Ther., 2003, 5, (2) 139–147.
- 6 Baneyx, F.: Recombinant protein expression in Escherichia coli. Curr. Opin. Biotechnol., 1999, 10, (5), 411–421.
- 7 Swartz, J.R.: Advances in Escherichia coli production of therapeutic proteins. Curr. Opin. Biotechnol., 2001, 12, (2), 195–201.
- 8 Andersen, D.C., Krummen, L.: Recombinant protein expression for therapeutic applications. Curr. Opin. Biotechnol., 2002, 13, 117–123.
- 9 Jana, S., Deb, J.K.: Strategies for efficient production of heterologous proteins in Escherichia coli. Appl. Microbiol. Biotechnol., 2005, 67, (3), 289–298.
- 10 Zhou, L., Zhang, K., Wanner, B.L.: Chromosomal expression of foreign and native genes from regulatable promoters in Escherichia coli. Methods Mol. Biol., 2004, 267, 123–134.
- 11 Sorensen, H.P., Mortensen, K.K.: Advanced genetic strategies for recombinant protein expression in Escherichia coli. J. Biotechnol., 2005, 115, 113–128.
- 12 Grabherr, R., Bayer, K.: Impact of targeted vector design on ColE1 plasmid replication. Trends Biotechnol., 2002, 20, (6), 257–260.
- 13 Grabherr, R., Nilsson, E., Striedner, G.: Bayer, K., Stabilizing plasmid copy number to improve recombinant protein production. Biotechnol. Bioeng., 2002, 77, (2), 142–147.
- 14 Menzella, H.G., Ceccarelli, E.A., Gramajo, H.C.: Novel Escherichia coli strain allows efficient recombinant protein production using lactose as inducer. Biotechnol. Bioeng., 2003, 82, 809–817.
- 15 Striedner, C., Cserjan-Puschmann, D., Pötschacher, W., Bayer, D.: Tuning the transcription rate of recombinant protein in strong Escherichia coli expression systems through repressor titration. Biotechnol. Bioeng., 2003, 19, 1427–1432.
- 16 Ryan, W., Collier, P., Loredo, L., Pope, J., Sachdev, R.: Growth kinetics of Escherichia coli and expression of a recombinant protein and its isoforms under heat shock conditions. Biotechnol. Bioeng., 1996, 12, 596–601.
- 17 Jechlinger, C., Szostak, D., Witte, W., Lubitz, D.: Altered temperature induction sensitivity of the lambda pR/cI857 system for controlled gene E expression in Escherichia coli. FEMS Microbiol. Lett., 1999, 173, (2), 347–352.
- 18 Hoffmann, F., Weber, J., Rinas, U.: Metabolic adaptation of Escherichia coli during temperature-induced recombinant protein production: 1. Readjustment of metabolic enzyme synthesis. Biotechnol. Bioeng., 2002, 80, (3), 313–319.
- 19 Weber, J., Hoffmann, F., Rinas, U.: Metabolic adaptation of Escherichia coli during temperature-induced recombinant protein production: 2. redirection of metabolic fluxes. Biotechnol. Bioeng., 2002, 80, (3), 320–330.
- 20 Schofield, D.A., Westwater, C., Dolan, J.W., Norris, J.S., Schmidt, M.G.: Tight regulation and modulation via a C1-regulated promoter in Escherichia coli and Pseudomonas aeruginosa. Curr. Microbiol., 2002, 44, (6), 425–430.
- 21 Simmons, L.C., Reilly, D., Klimowski, L., Raju, T.S., Meng, G., Sims, P., Hong, K., Shields, R.L., Damico, L.A., Rancatore, P., Yansura, D.G.: Expression of full-length immunoglobulins in Escherichia coli: rapid and efficient production of aglycosylated antibodies. J. Immunol. Methods., 2002, 263, (1–2), 133–147.
- 22 Phue, J.N., Shiloach, J.: Impact of dissolved oxygen concentration on acetate accumulation and physiology of E. coli BL21, evaluating transcription levels of key genes at different dissolved oxygen conditions. Metab. Eng., 2005, 7, (5–6), 353–363.
- 23 Matsui, T., Sato, H., Sato, S., Mukataka, S., Takahashi, J.: Effects of nutritional conditions on plasmid stability and production of tryptophan synthase by a recombinant Escherichia coli. Agric. Biol. Chem., 1990, 54, (3), 619–624.
- 24 Thiry, M., Cingolani, D.: Optimzing scale-up fermentation processes. Trends Biotechnol., 2002, 20, (3), 103–105.
- 25 Zhang, Y., Taiming, L., Liu, J.: Low temperature and glucose enhanced T7 RNA polymerase-based plasmid stability for increasing expression of glucagon-like peptide-2 in Escherichia coli. Protein Expr. Purif., 2003, 29, 132–139.
- 26 Gottesman, S.: Proteases and their targets in Escherichia coli. Annu. Rev. Genet., 1996, 30, 465–506.
- 27 Damerau, K., St. John, A.C.: Role of Clp protease subunits in degradation of carbon starvation proteins in Escherichia coli. J. Bacteriol., 1993, 175, (1), 53–63.
- 28 Miksch, G., Bettenworth, F., Friehs, K., Flaschel, E., Saalbach, A., Twellmann, T., Nattkemper, T.W.: Libraries of synthetic stationary-phase and stress promoters as a tool for fine-tuning of expression of recombinant proteins in Escherichia coli. J. Biotechnol., 2005, 120, (1), 25–37.
- 29 Kane, J.F.: Effects or rare codon clusters on high-level expression of heterologous proteins in Escherichia coli. Curr. Opin. Biotechnol., 1995, 6, (5), 494–500.
- 30 McNulty, D., Claffee, B.A., Huddleston, M.J., Kane, J.F.: Mistranslational errors associated with the rare arginine codon CGG in Escherichia coli. Protein Expr. Purif., 2003, 27, 365–374.
- 31 Gustafsson, C., Govindarajan, S., Minshull, J.: Codon bias and heterologous protein expression. Trends Biotechnol., 2004, 22, (7), 346–353.
- 32 Carrio, M.M., Villaverde, A.: Construction and deconstruction of bacterial inclusion bodies. J. Biotechnol., 2002, 96, 2–12.
- 33 Fahnert, B., Lilie, H., Neubauer, P.: Inclusion bodies: formation and utilisation. Adv. Biochem. Eng. Biotechnol., 2004, 89, 93–142.
- 34 Baneyx, F., Mujacic, M.: Recombinant protein folding and misfolding in Escherichia coli. Nat. Biotechnol., 2004, 22, (11), 1399–408.
- 35 Thanh, H.L., Hoffmann, F.: Optimized production of active alpha-glucosidase by recombinant Escherichia coli. Evaluation of processes using in vivo reactivation from inclusion bodies. Biotechnol. Prog., 2005, 21, (4), 1053–1061.
- 36 Hoffmann, F., Posten, C., Rinas, U.: Kinetic model of in vivo folding and inclusion body formation in recombinant Escherichia coli. Biotechnol. Bioeng., 2001, 72, 315–322.
- 37 Schlieker, C., Bukau, B., Mogk, A.: Prevention and reversion of protein aggregation by molecular chaperones in the E. coli cytosol: implications for their applicability in biotechnology. J. Biotechnol., 2002, 96, 13–21.
- 38 Qiu, J., Swartz, J.R., Georgiou, G.: Expression of active human tissue-type plasminogen activator in Escherichia coli. Appl. Environ. Microbiol., 1998, 64, (12), 4891–4896.
- 39 Huang, S., Elliott, R.C., Liu, P.-S., Koduri, J.L. et al., Specificity of cotranslational amino-terminal processing of proteins in yeast. Biochemistry, 1989, 26, 8242–8246.
- 40 Hirel, P.-H., Schmitter, J.-M., Dessen, P., Fayat, G., Blanquet, S.: Extent of N-terminal methionine excision from Escherichia coli proteins is governed by the side-chain length of the penultimate amino acid. Proc. Natl. Acad. Sci. USA, 1989, 86, 8247–8251.
- 41 Meinnel, T., Mechulam, Y., Blanquet, S.: Methionine as translational start signal: a review of the enzymes of the pathway in Escherichia coli. Biochimie, 1993, 75, (12), 1061–1075.
- 42 Lowther, W.T., Matthews, B.W.: Structure and function of methionine aminopeptidases. Biochim. Biophys. Acta, 2000, 1477, 157–167.
- 43 Sandman, K., Grayling, R.A., Reeve, J.N.: Improved N-terminal processing of recombinant proteins synthesized in Escherichia coli. Biotechnology (NY), 1995, 13, (5), 504–506.
- 44 Jeong, K.J., Lee, S.Y.: Secretory production of human granulocyte colony-stimulating factor in Escherichia coli. Protein Expr. Purif., 2001, 23, 311–318.
- 45 Skerra, A., Plückthun, A.: Assembly of a functional immunoglobulin Fv fragment in Escherichia coli. Science, 1988, 240, (4855), 1038–1041.
- 46 Better, M., Chang, C.P., Robinson, R.R., Horwitz, A.H.: Escherichia coli secretion of an active chimeric antibody fragment. Science, 1988, 240, (4855), 1041–1043.
- 47 Weir, A.N., Nesbitt, A., Chapman, A.P., Popplewell, A.G., Antonow, P., Lawson, A.D.: Formatting antibody fragments to mediate specific therapeutic functions. Biochem. Soc. Trans., 2002, 30, (4), 512–516.
- 48 Chen, C., Snedecor, B., Nishihara, J.C., Joly, J.C., McFarland, N., Andersen, D.C., Battersby, J.E., Champion, K.M.: High-level accumulation of a recombinant antibody fragment in the periplasm of Escherichia coli requires a triple-mutant (degP prc spr) host strain. Biotechnol. Bioeng., 2004, 85, (5), 463–474.
- 49 Corisdeo, S., Wang, B.: Functional expression and display of an antibody Fab fragment in Escherichia coli: Study of vector designs and culture conditions. Protein Expr. Purif., 2004, 34, 270–279.
- 50 Wall, J.G., Plückthun, A.: Effects of overexpressing folding modulators on the in vivo folding of heterologous proteins in Escherichia coli. Curr. Opin. Biotechnol., 1995, 6, (5), 507–516.
- 51 Georgiou, G., Valax, P.: Expression of correctly folded proteins in Escherichia coli. Curr. Opin. Biotechnol., 1996, 7, (2), 190–197.
- 52 Jonda, S., Huber-Wunderlich, M., Glockshuber, R., Mössner, E.: Complementation of DsbA deficiency with secreted thioredoxin variants reveals the crucial role of an efficient dithiol oxidant for catalyzed protein folding in the bacterial periplasm. EMBO J., 1999, 18, (12), 3271–3281.
- 53 Levy, J.H., Weisinger, A., Ziomek, C.A., Echelard, Y.: Recombinant antithrombin: production and role in cardiovascular disorder. Semin. Thromb. Hemost., 2001, 27, (4), 405–416.
- 54 Zola, W., Nicholson, D.: Increased yield and activity of soluble single-chain antibody fragments by combining high-level expression and the Skp periplasmic chaperonin. Protein Expr. Purif., 2001, 23, 289–295.
- 55 Mavrangelos, C., Thiel, M., Adamson, P.J., Millard, D.J. et al., Production of correctly folded Fab antibody fragment in the cytoplasm of Escherichia coli trxB gor mutants via the coexpression of molecular chaperones. Protein Expr. Purif., 2001, 23, 338–347.
- 56 Georgiou, G., Segatori, L.: Preparative expression of secreted proteins in bacteria: status report and future prospects. Curr. Opin. Biotechnol., 2005, 16, 538–545.
- 57 Majander, K., Anton, L., Antikainen, J., Lnag, H., Brummer, M., Korhonen, T.K., Westerlund-Wikström, B.: Extracellular secretion of polypeptides using a modified Escherichia coli flagellar secretion apparatus. Nature Biotechnol., 2005, 23, (4), 475–481.
- 58 Ray, M.V., Meenan, C.P., Consalvo, A.P., Smith, C.A., Parton, D.P., Sturmer, A.M., Shields, P.P., Mehta, N.M.: Production of salmon calcitonin by direct expression of a glycine-extended precursor in Escherichia coli. Protein Expr. Purif., 2002, 26, (2), 249–259.
- 59 Fernandez, L.A., de Lorenzo, V.: Formation of disulphide bonds during secretion of proteins through the periplasmic-independent type I pathway. Mol. Microbiol., 2001, 40, (2), 332–346.
- 60 Blight, M.A., Chervaux, C., Holland, I.B.: Protein secretion pathway in Escherichia coli. Curr. Opin. Biotechnol., 1994, 5, (5), 468–474.
- 61 Economou, A.: Following the leader: bacterial protein export through the Sec pathway. Trends Microbiol., 1999, 7, (8), 315–320.
10.1016/S0966-842X(99)01555-3 Google Scholar
- 62 Humphreys, D.P., Sehdev, M., Chapman, A.P., Ganesh, R. et al., High-level periplasmic expression in Escherichia coli using a eukaryotic signal peptide: importance of codon usage at the 5' end of the coding sequence. Protein Expr. Purif., 2000, 20, (2), 252–264.
- 63 Bothmann, H., Plückthun, A.: The periplasmic Escherichia coli peptidylprolyl cis, trans-isomerase FkpA. I. Increased functional expression of antibody fragments with and without cis-prolines. J. Biol. Chem., 2000, 275, (22), 17100–17105.
10.1074/jbc.M910233199 Google Scholar
- 64 Joly, J.C., Leung, W.S., Swartz, J.R.: Overexpression of Escherichia coli oxidoreductases increases recombinant insulin-like growth factor-I accumulation. Proc. Natl. Acad. Sci. USA, 1998, 95, 2773–2777.
- 65 Gemmill, T.R., Trimble, R.B.: Overview of N- and O-linked oligosaccharide structures found in various yeast species. Biochim. Biophys. Acta., 1999, 1426, (2), 227–237.
- 66 Daly, R., Hearn, M.T.: Expression of heterologous proteins in Pichia pastoris: A useful experimental tool in protein engineering and production.. J. Mol. Recogn., 2005, 18, 119–138.
- 67 Cereghino, J.L., Cregg, J.M.: Heterologous protein expression in the methylotrophic yeast Pichia pastoris. FEMS Microbiol. Rev., 2000, 24, (1), 45–66.
- 68 Mendoza-Vega, O., Sabatie, J., Brown, S.W.: Industrial production of heterologous proteins by fed-batch cultures of the yeast Saccharomyces cerevisiae. FEMS Microbiol. Rev., 1994, 15, (4), 369–410.
- 69 Kim, K.Y., Kim, H.E., Lee, K.H., Han, W., Yi, M.J., Jeong, J., Oh, B.H.: Two-promoter vector is highly efficient for overproduction of protein complexes. Protein Sci., 2004, 13, 1698–1703.
- 70 Cannizzaro, C., Valentinotti, S., von Stockar, U.: Control of yeast fed-batch process through regulation of extracellular ethanol concentration. Bioprocess Biosyst. Eng., 2004, 26, (6), 377–383.
- 71 Sonnleitner, B., Käppeli, O.: Growth of Saccharomyces cerevisiae is controlled by its limited respiratory capacity: formulation and verification of a hypothesis. Biotechnol. Bioeng., 1986, 28, 927–937.
- 72 Goodrick, J.C., Xu, M., Finnegan, R., Schilling, B.M., Schiavi, S., Hoppe, H., Wan, N.C.: High-level expression and stabilization of recombinant human chitinase produced in a continuous constitutive Pichia pastoris expression system. Biotechnol. Bioeng., 2001, 74, (6), 492–497.
- 73 Cereghino, G.P.L., Cereghino, J.L., Ilgen, C., Cregg, J.M.: Production of recombinant proteins in fermenter cultures of the yeast Pichia pastoris. Curr. Opin. Biotechnol., 2002, 13, 329–332.
- 74 Sinha, J., Plantz, B.A., Zhang, W., Gouthro, M., Schlegel, V., Liu, C.P., Meagher, M.M.: Improved production of recombinant ovine Interferon-τ by Mut+ strain of Pichia pastoris using an optimized methanol feed profile. Biotechnol. Prog., 2003, 19, 794–802.
- 75 Kim, M.D., Lee, T.H., Lim, H.K., Seo, J.H.: Production of antithrombotic hirudin in GAL1-disrupted Saccharomyces cerevisiae. Appl. Microbiol. Biotechnol., 2004, 65, (3), 259–262.
- 76 Kim, Y.J., Park, S., Oh, Y.K., Kang, W., Kim, H.S., Lee, E.Y.: Purification and characterization of human caseinomacropeptide produced by a recombinant Saccharomyces cerevisiae. Protein Expr. Purif., 2005, 41, (2), 441–446.
- 77 Degelmann, A., Müller, F., Sieber, H., Jenzelewski, V. et al., Strain and process development for the production of human cytokines in Hansenula polymorpha. FEMS Yeast Res., 2002, 2, (3), 349–361.
- 78 Kjeldsen, T.: Yeast secretory expression of insulin precursors. Appl. Microbiol. Biotechnol., 2000, 54, 277–286.
- 79 Sinha, J., Plantz, B.A., Inan, M., Meagher, M.M.: Causes of proteolytic degradation of secreted recombinant proteins produced in methylotrophic yeast Pichia pastoris: case study with recombinant ovine interferon-tau. Biotechnol. Bioeng., 2005, 89, (1), 102–112.
- 80 Werten, M.W., de Wolf, F.A.: Reduced proteolysis of secreted gelatin and Yps1-mediated alpha-factor leader processing in a Pichia pastoris kex2 disruptant. Appl. Environ. Microbiol., 2005, 71, (5), 2310–2317.
- 81 Schaefer, S., Piontek, M., Ahn, S. J., Papendieck, A., Janowicz, Z.A., Timmermans, I., Gellissen, G., Recombinant hepatitis B vaccine – disease characterization and vaccine production, in: Gellissen, G. (Ed.), Hansenula polymorpha – Biology and applications, Wiley VCH, Weinheim 2002, pp.175-210.
- 82 Bartelsen, O., Barnes, C.S., Gellissen, G., Production of anticoagulants in Hansenula polymorpha, in: Gellissen, G. (Ed.), Hansenula polymorpha – Biology and Applications, (Wiley-VCH, Weinheim 2002, pp. 211–228.
- 83 Kjaerulff, S., Jensen, M.R.: Comparison of different signal peptides for secretion of heterologous proteins in fission yeast. Biochem. Biophys. Res. Commun., 2005, 336, 974–982.
- 84 Wang, T.T., Choi, Y.J., Lee, B.H.: Transformation systems of non-Saccharomyces yeasts. Crit. Rev. Biotechnol., 2001, 21, (3), 177–218.
- 85 Flores, C.L., Rodriguez, C., Petit, T., Gancedo, C.: Carbohydrate and energy-yielding metabolism in non-conventional yeasts. FEMS Microbiol. Rev., 2000, 24, 507–529.
- 86 Hamilton, S.R., Bobrowicz, P., Bobrowicz, B., Davidson, R.C. et al., Production of complex human glycoproteins in yeast. Science, 2003, 301, 1244–1246.
- 87 Gerngross, T.U.: Advances in the production of human therapeutic proteins in yeasts and filamentous fungi. Nat. Biotechnol., 2004, 22, (11), 1409–1414.
- 88 Wildt, S., Gerngross, T.U.: The humanization of N-glycosylation pathways in yeast. Nat. Rev. Microbiol., 2005, 3, 119–128.
- 89 Schweizer, H.P.: Vectors to express foreign genes and techniques to monitor gene expression in pseudomonads. Curr. Opin. Biotechnol., 2001, 12, 439–445.
- 90 Srinivasan, S., Barnard, G.C., Gerngross, T.U.: Production of recombinant proteins using multiple copy gene integration in high-cell-density fermentations of Ralstonia eutropha. Biotechnol. Bioeng., 2003, 84, (1), 114–120.
- 91 Li, W., Zhou, X., Lu, P.: Bottlenecks in the expression and secretion of heterologous proteins in bacillus subtilis. Res. Microbiol., 2004, 155, 605–610.
- 92 Bélanger, L., Figueira, M.M., Bourque, D., Morel, L. et al., Production of heterologous protein by Methylobacterium extorquens in high cell density fermentation. FEMS Microbiol. Lett., 2004, 231, 197–204.
- 93 Schaerlaekens, K., Lammertyn, E., Geukens, N., De Keersmaeker, S., Anné, J., Van Mellaert, L.: Comparison of the Sec and Tat secretion pathways for the heterologous protein production by Streptomyces lividans. J. Biotechnol., 2004, 112, 279–288.
10.1016/j.jbiotec.2004.05.004 Google Scholar
- 94 Westers, L., Westers, H., Quax, W.J.: Bacillus subtilis as cell factory for pharmaceutical proteins: a biotechnological approach to optimize the host organism. Biochim. Biophys. Acta, 2004, 1694, 299–310.
- 95 Ferreira, L.C.S., Ferreira, R.C.C., Schuhmann, W.: Bacillus subtilis as a tool for vaccine development: from antigen factories to delivery vectors. An. Acad. Bras. Cienc., 2005, 77, (1), 113–124.
- 96 Zhang, Z., Gildersleeve, J., Yang, Y.Y., Xu, R. et al., A new strategy for the synthesis of glycoproteins. Science, 2004, 303, (56), 371–373.
- 97 Hsieh-Wilson, L.C.: Tailor-made glycoproteins. Trends Biotechnol., 2004, 22, (10), 489–491.
- 98 Punt, P.J., van Biezen, N., Conesa, A., Albers, A., Mangnus, J., van den Hondel, C.: Filamentous fungi as cell factories for heterologous protein production. Trends Biotechnol., 2002, 20, (5), 200–206.
- 99 Andersen, D.C., Reilly, D.E.: Production technologies for monoclonal antibodies and their fragments. Curr. Opin. Biotechnol., 2004, 15, 456–462.
- 100 Schmidt, F.R.: Optimization and scale up of industrial fermentation processes. Appl. Microbiol. Biotechnol., 2005, 68, (4), 425–435.
- 101 Zhang, J., Reddy, J., Buckland, B., Greasham, R.: Toward consistent and productive complex media for industrial fermentations: studies on yeast extract for a recombinant yeast fermentation process. Biotechnol. Bioeng., 2003, 82, 640–652.
- 102 Whifin, V.S., Cooney, M.J., Cord-Ruwisch, R.: Online detection of feed demand in high cell density cultures of Escherichia coli by measurement of changes in dissolved oxygen transients in complex media. Biotechnol. Bioeng., 2004, 85, (4), 422–433.
- 103 Neubauer, P., Lin, H.Y., Mathiszik, B.: Metabolic load of recombinant protein production: inhibition of cellular capacities for glucose uptake and respiration after induction of a heterologous gene in Escherichia coli. Biotechnol. Bioeng, 2003, 83, (1), 53–6.
- 104 Lin, F.Y., Chen, C.S., Chen, W.Y., Yamamoto, S.: Microcalorimetric studies of the interaction mechanisms between proteins and Q-Sepharose at pH near the isoelectric point (pI). Effects of NaCl concentration, pH value, and temperature. J. Chromatogr. A, 2001, 912, 281–289.
- 105 Cserjan-Puschmann, M., Kramer, W., Duerrschmid, E., Striedner, G., Bayer, K.: Metabolic approaches for the optimisation of recombinant fermentation processes. Appl. Microbiol. Biotechnol., 1999, 53, (1), 43–50.
- 106 Zhang, W., Smith, L.A., Plantz, B.A., Schlegel, V.L., Meagher, M.M.: Design of methanol feed control in Pichia pastoris fermentations based upon a growth model. Biotechnol. Prog., 2002, 18, 1392–1399.
- 107 Boström, M., Larsson, G.: Process design for recombinant protein production based on the promoter, PmalK. Appl. Microbiol. Biotechnol., 2004, 66, (2), 200–20.
- 108 Ihssen, J., Egli, T.: Specific growth rate and not cell density controls the general stress response in Escherichia coli. Microbiology, 2004, 150, (6), 1637–164.
- 109 Mattanovich, D., Gasser, B., Hohenblum, H., Sauer, M.: Stress in recombinant protein producing yeasts. J. Biotechnol., 2004, 113, 121–135.
- 110 Tsai, L.B., Lu, H.S., Kenney, W.C., Curless, C.C. et al., Control of misincorporation of de novo synthesized norleucine into recombinant interleukin-2 in E. coli. Biochem. Biophys. Res. Commun., 1988, 156, (2), 733–739.
- 111 Lu, H.S., Tsai, L.B., Kenney, W.C., Lai, P.H.: Identification of unusual replacement of methionine by norleucine in recombinant interleukin-2 produced by E. coli. Biochem. Biophys. Res. Commun., 1988, 156, 807–813.
- 112 Brunner, D.P., Harbour, G.C., Kirschner, R.J., Pinner, J.F., Garlick, R.L., Fermentation media and methods for controlling norleucine content in polypeptides. Patent EP0737752.
- 113 Skibsted, C., Lindemann, D., Roca, W., Olsson, D.: On-line bioprocess monitoring with a multi-wavelength fluorescence sensor using multivariate calibration. J. Biotechnol., 2001, 88, 47–57.
- 114 Clementschitsch, F., Kern, J., Pötschacher, F., Bayer, K.: Sensor combination and chemometric modeling for improved process monitoring in recombinant E. coli fed-batch cultivations. J. Biotechnol., 2005, 120, 183–196.
- 115 Hantelmann, K., Kollecker, M., Hüll, D., Hitzmann, B., Scheper, T.: Two-dimensional fluorescence spectroscopy: A novel approach for controlling fed-batch cultivations. J. Biotechnol., doi:10.1016/j.jbiotec.2005.07.016.
- 116 Reischer, H., Schotola, I., Striedner, G., Pötschacher, F., Bayer, K.: Evaluation of the GFP signal and its aptitude for novel on-line monitoring strategies of recombinant fermentation processes. J. Biotechnol., 2004, 108, (2), 115–125.
- 117 Franzén, B., Becker, S., Mikkola, R., Tidblad, K., Tjernberg, A., Birnbaum, S.: Characterization of periplasmic Escherichia coli protein expression at high cell densities. Electrophoresis, 1999, 20, 790–797.
10.1002/(SICI)1522-2683(19990101)20:4/5<790::AID-ELPS790>3.0.CO;2-A CASPubMedWeb of Science®Google Scholar
- 118 Jürgen, B., Lin, H.Y., Riemschneider, S., Scharf, C., Neubauer, P., Schmid, R., Hecker, M., Schweder, T.: Monitoring of genes that respond to overproduction of an insoluble recombinant protein in Escherichia coli glucose-limited fed-batch fermentations. Biotechnol. Bioeng., 2000, 70, (2), 217–224.
- 119 Dürrschmid, K., Marzban, G., Dürrschmid, E., Striedner, G., Clementschitsch, F., Cserjan-Puschmann, M., Bayer, K.: Monitoring of protein profiles for the optimization of recombinant fermentation processes using public domain databases. Electrophoresis, 2003, 24, (1–2), 303–310.
- 120 Champion, K.M., Nishihara, J.C., Aldor, I.S., Moreno, G.T., Andersen, D., Stults, K.L., Vanderlaan, M.: Comparison of the Escherichia coli proteomes for recombinant human growth hormone producing and nonproducing fermentations. Proteomics, 2003, 3, 1365–1373.
- 121 Lee, P.S., Shaw, L.B., Choe, L.H., Mehra, A., Hatzimanikatis, V., Lee, K.H.: Insights into the relation between mRNA and protein expression patters: II. Experimental observations in Escherichia coli. Biotechnol. Bioeng., 2003, 84, (7), 834–841.
- 122 Yoon, S.H., Han, M.J., Lee, S.Y., Jeong, K.Y., Yoo, J.S., Combined transcriptome and proteome analysis of Escherichia coli during high cell density culture. Biotechnol. Bioeng., 2003, 81, (7), 753–767.
- 123 Gadgil, M., Kapur, V., Hu, W.S.: Transcriptional response of Escherichia coli to temperature shift. Biotechnol. Prog., 2005, 21, 689–699.
- 124 Andersen, D.C., Swartz, J., Ryll, T., Lin, N., Snedecor, B.: Metabolic oscillations in an E. coli fermentation. Biotechnol. Bioeng., 2001, 75, (2), 212–218.
- 125 van Hee, P., Middelberg, A.P.J., van der Lans, R.G.J.M., van der Wielen, L.A.: Relation between cell disruption conditions, cell debris particle size, and inclusion body release. Biotechnol. Bioeng., 2004, 88, (1), 100–110.
- 126 Rathore, A.S., Bilbrey, R.E., Steinmeyer, D.E.: Optimization of an osmotic shock procedure for isolation of a protein product expressed in E. coli. Biotechnol. Prog., 2003, 19, 1541–1546.
- 127 Shepard, S.R., Stone, C., Cook, S., Bouvier, A., Boyd, G., Weatherly, G., Lydiard, D., Schrimsher, J.: Recovery of intracellular recombinant proteins from the yeast Pichia pastoris by cell permeabilization. J. Biotechnol., 2002, 99, 149–160.
- 128 Tsoka, S., Ciniawskyj, O.C., Thomas, O.R.T., Titchener-Hooker, N.J., Hoare, M.: Selective flocculation and precipitation for the improvement of virus-like particle recovery from yeast homogenate. Biotechnol. Prog., 2000, 16, 661–667.
- 129 Persson, J., Lester, P.: Purification of antibody and antibody-fragment from E. coli homogenate using 6, 9-diamino-2-ethoxyacridine lactate as precipitation agent. Biotechnol. Bioeng., 2004, 87, (3), 424–434.
- 130 Hilbrig, F., Freytag, R.: Protein purification by affinity precipitation. J. Chromatogr. B, 2003, 790, (1-2), 79–90.
- 131 Staby, A., Johansen, N., Wahlstrom, H., Mollerup, I.: Comparison of loading capacities of various proteins and peptides in culture medium and in pure state. J. Chromatogr. A, 1998, 827, 311–318.
- 132 Kato, Y., Nakamura, K., Kitamura, T., Hasegawa, M., Sasaki, H.: Hydrophobic interaction chromatography at low salt concentration for the capture of monoclonal antibodies. J. Chromatogr. A, 2004, 1036, (1), 45–50.
- 133 Fahrner, R.L., Whitney, D.H., Vanderlaan, M., Blake, G.S.: Perfomance comparison of protein A affinity-chromatography sorbents for purifying recombinant monoclonal antibodies. Biotechnol. Appl. Biochem., 1999, 30, 121–128.
- 134 Choe, W.S., Clemmitt, R.H., Chase, H.A., Middelberg, A.P.J.: Comparison of histidine-tag capture chemistries for purification following chemical extraction. J. Chromatogr. A, 2002, 953, 111–121.
- 135 Ueda, E.K.M., Gout, P.W., Morganti, L.: Current and prospective applications of metal ion-protein binding. J. Chromatogr. A, 2003, 988, 1–23.
- 136 Follman, D.K., Fahrner, R.L.: Factorial screening of antibody purification processes using three chromatography steps without protein A. J. Chromatogr. A, 2004, 1024, 79–85.
- 137 Jungbauer, A., Hahn, R.: Engineering protein A chromatography. Curr. Opin. Drug Discov. Devel., 2004, 7, (2), 248–256.
- 138 Hahn, R., Shimahara, K., Steindl, F., Jungbauer, A.: Comparison of protein A affinity sorbents III. Life time study. J. Chromatogr. A, 2006, 1102, (1–2), 224–231.
- 139 Labrou, N.E.: Design and selection of ligands for affinity chromatography. J. Chromatogr. B, 2003, 790, 67–78.
- 140 Xiang, H., Wynn, R., Nguyen, L.H.T., Ross, O.H., Ahrens, D.P., ÓNeil, K.T., Hollis, G.F., Patrick, D.R.: Immobilized metal-ion affinity chromatography of recombinant Fab protein OPG C11 in the presence of EDTA-Mg(II). J. Chromatogr. A, 2002, 978, 153–164.
- 141 Chase, H.A.: Purification of proteins by adsorption chromatography in expanded beds. Trends Biotechnol., 1994, 12, (8), 296–303.
- 142 Chase, H.A.: The use of affinity adsorbents in expanded bed adsorption. J. Mol. Recogn., 1998, 11, 217–221.
10.1002/(SICI)1099-1352(199812)11:1/6<217::AID-JMR426>3.0.CO;2-D CASPubMedWeb of Science®Google Scholar
- 143 Thoemmes, J.: Fluidized bed adsorption as a primary recovery step in protein purification. Adv. Biochem. Eng. Biotechnol., 1997, 58, 185–230.
- 144 Garke, G., Deckwer, W.D., Anspach, F.B.: Preparative two-step purification of recombinant human basic fibroblast growth factor from high-cell-density cultivation of Escherichia coli. Escherichia coli. J. Chromatogr. B, 2000, 737, (1–2), 25–38.
- 145 Ohashi, R., Otero, J.M., Chwistek, A., Yamato, I., Hamel, J.F.P.: On-line purification of monoclonal antibodies using an integrated stirred-tank reactor/expanded-bed adsorption system. Biotechnol. Prog., 2002, 18, 1292–1300.
- 146 Vergnault, H., Mercier-Bonin, M., Willemot, R.M.: Physicochemical parameters involved in the interaction of Saccharomyces cerevisiae cells with ion-exchange adsorbents in expanded bed chromatography. Biotechnol. Prog., 2004, 20, (5), 1534–1542.
- 147 Gräslund, S., Eklund, M., Falk, R., Uhlén, M., Nygren, P.A., Stahl, S.: A novel affinity gene fusion allowing protein A-based recovery of non-immunoglobulin gene products. J. Biotechnol., 2002, 99, 41–50.
- 148 Chen, W.D., Dong, X.Y., Sun, Y.: Modeling of the whole expanded-bed protein adsorption process with yeast cell suspensions as feedstock. J. Chromatogr. A, 2003, 1012, (1), 1–10.
- 149 De Bernardez Clark,, E.: Protein refolding for industrial processes. Curr. Opin. Biotechnol., 2001, 12, 202–207.
- 150 Middelberg, A.P.J.: Preparative protein refolding. Trends Biotechnol., 2002, 20, (10), 437–443.
- 151 Tsumoto, C., Ejima, D., Kumagai, W., Arakawa, D.: Practical considerations in refolding proteins from inclusion bodies. Protein Expr. Purif., 2003, 28, 1–8.
- 152 Menzella, H.G., Gramajo, H.C., Ceccarelli, E.A.: High recovery of prochymosin from inclusion bodies using controlled air oxidation. Protein Expr. Purif., 2002, 25, 248–255.
- 153 Buswell, A.M., Ebtinger, M., Vertés, A.A., Middelberg, A.P.J.: Effect of operating variables on the yield of recombinant trypsinogen for a pulse-fed dilution-refolding reactor. Biotechnol. Bioeng., 2002, 77, 435–444.
- 154 Tsumoto, K., Umetsu, M., Kumagai, I., Ejima, D., Philo, J.S., Arakawa, T.: Role of arginine in protein refolding, solubilization and purification. Biotechnol. Prog., 2004, 20, 1301–1308.
- 155 St. John, R.J., Carpenter, J.F., Randolph, T.W.: High-pressure refolding of disulfide-cross-linked lysozyme aggregates: Thermodynamics and optimization. Biotechnol. Prog., 2002, 18, 565–571.
- 156 Vallejo, L.F., Rinas, U.: Strategies for the recovery of active proteins through refolding of bacterial inclusion body proteins. Microb. Cell Fact., 2004, 3, 11.
- 157 Ho, J.G.S., Middelberg, A.P.J.: Estimating the potential refolding yield of recombinant proteins expressed as inclusion bodies. Biotechnol. Bioeng., 2004, 87, (5), 584–592.
- 158 Stempfer, G., Höll-Neugebauer, B., Rudolph, R.: Improved refolding of an immobilized fusion protein. Nat. Biotechnol., 1996, 14, 329–334.
- 159 Batas, B., Chadhuri, J.B.: Protein refolding at high concentration using size-exclusion chromatography. Biotechnol. Bioeng., 1996, 50, 16–23.
10.1002/(SICI)1097-0290(19960405)50:1<16::AID-BIT3>3.0.CO;2-4 CASPubMedWeb of Science®Google Scholar
- 160 Berdichevsky, Y., Lamed, R., Frenkel, D., Gophna, U. et al., Matrix-assisted refolding of single-chain Fv-cellulose binding domain fusion proteins. Protein Expr. Purif., 1999, 17, 249–259.
- 161 Geng, X., Bai, Q., Zhang, Y., Li, X., Wu, D.: Refolding and purification of interferon-gamma in industry by hydrophobic interaction chromatography. J. Biotechnol., 2004, 113, 137–149.
- 162 Jungbauer, A., Kaar, W., Schlegl, R.: Folding and refolding of proteins in chromatographic beds. Curr. Opin. Biotechnol., 2004, 15, (5), 487–49.
- 163 Altamirano, M.M., Golbik, R., Zahn, R., Buckle, A.M., Fersht, A.R.: Refolding chromatography with immobilized mini-chaperones. Proc. Natl. Acad. Sci. USA, 1997, 94, (8), 3576–3578.
- 164 Altamirano, M.M., Garcia, C., Possani, L.D., Fersht, A.R.: Oxidative refolding chromatography: folding of the scorpion toxin Cn5. Nat. Biotechnol., 1999, 17, 187–191.
- 165 Altamirano, M.M., Woolfson, A., Donda, A., Shamshiev, A.: Ligand-independent assembly of recombinant human CD1 by using oxidative refolding chromatography. Proc. Natl. Acad. Sci. USA, 2001, 98, (6), 3288–3293.
- 166 Lu, H.S., Fausset, P.R., Sotos, L.S., Clogston, C.L., Rohde, M.F., Stoney, K.S., Herman, A.C.: Isolation and characterization of three recombinant human granulocyte colony stimulating factor His→Gln isoforms produced in Escherichia coli. Protein Expr. Purif., 1993, 4, (5), 465–472.
- 167 Lin, F.Y., Chen, W.Y., Hearn, M.T.W.: Thermodynamic analysis of the interaction between proteins and solid surfaces: application to liquid chromatography. J. Mol. Recognit., 2002, 15, 55–93.
- 168 Yamamoto, S.: Electrostatic interaction chromatography process for protein separations: impact of engineering analysis of biorecognition mechanism on process optimization. Chem. Eng. Technol., 2005, 28, (11), 1387–1393.
- 169 Frey, D.D.: Local-equilibrium behavior of retained pH and ionic strength gradients in preparative chromatography. Biotechnol. Prog., 1996, 12, 65–72.
- 170 DePhillips, P., Lenhoff, A.M.: Determinants of protein retention characteristics on cation-exchange adsorbents. J. Chromatogr. A, 2001, 933, 57–72.
- 171 Knudsen, H.L., Fahrner, R.L., Xu, Y., Norling, L.A., Blank, G.S.: Membrane ion-exchange chromatography for process-scale antibody purification. J. Chromatogr. A, 2001, 907, (1–2), 145–154.
- 172 Curtis, S., Lee, K., Blank, G.S., Brorson, K., Xu, Y.: Generic/matrix evaluation of SV40 clearance by anion exchange chromatography in flow-through mode. Biotechnol. Bioeng., 2003, 84, (2), 179–186.
- 173 Graumann, K., Ebenbichler, A.A.: Development and scale up of preparative HIC for the purification of a recombinant therapeutic protein. Chem. Eng. Techn., 2005, 28, (11), 1398–1407.
- 174 Oscarsson, S.: Factors affecting protein interaction at sorbent interfaces. J. Chromatogr. B, 1997, 699, 117–131.
- 175 Oscarsson, S., Karsnäs, P.: Salt-promoted adsorption of proteins onto amphiphilic agarose-based adsorbents II. Effects of salt and salt concentration. J. Chromatogr. A, 1998, 803, 83–93.
- 176 Machold, C., Deinhofer, K., Hahn, R., Jungbauer, A.: Hydrophobic interaction chromatography of proteins II. Comparison of selectivity. J. Chromatogr. A, 2002, 972, 3–19.
- 177 Hahn, R., Deinhofer, K., Machold, C., Jungbauer, A.: Hydrophobic interaction chromatography of proteins II. Binding capacity, recovery and mass transfer properties. J. Chromatogr. B, 2003, 790, 99–114.
- 178 Shukla, A.A., Peterson, J., Sorge, L., Lewis, P., Thomas, S., Waugh, S.: Preparative purification of a recombinant protein by hydrophobic interaction chromatography: Modulation of selectivity by the use of chaotropic additives. Biotechnol. Prog., 2002, 18, 556–564.
- 179 McNay, J.L.M., Fernandez, E.J.: Protein unfolding during reversed-phase chromatography: I. Effect of surface properties and duration of adsorption. Biotechnol. Bioeng., 2001, 76, 224–232.
- 180 McNay, J.L.M., ÓConnell, J.P., Fernandez, E.J.: Protein unfolding during reversed-phase chromatography: II. Role of salt type and ionic strength. Biotechnol. Bioeng., 2001, 76, 233–240.
- 181 Tibbs Jones, T., Fernandez, E.J.: Hydrophobic interaction chromatography selectivity changes among three stable proteins: conformation does not play a major role. Biotechnol. Bioeng., 2004, 87, (3), 388–399.
- 182 Kundu, A., Cramer, S.: Low-molecular-weight displacers for high-resolution protein separations. Anal. Biochem., 1997, 248, (1), 111–116.
- 183 Shukla, A.A., Sunasara, K.M., Rupp, R.G., Cramer, S.M.: Hydrophobic charge induction chromatography of proteins. Biotechnol. Bioeng., 2000, 68, (6), 672–680.
10.1002/(SICI)1097-0290(20000620)68:6<672::AID-BIT11>3.0.CO;2-Q CASPubMedWeb of Science®Google Scholar
- 184 Sunasara, K.M., Xia, F., Gronke, R.S., Cramer, S.M.: Application of hydrophobic interaction displacement chromatography for an industrial protein purification. Biotechnol. Bioeng., 2003, 82, 330–339.
- 185 Barnthouse, K.A., Trompeter, W., Jones, R., Inampudi, P., Rupp, R., Cramer, S.M.: Cation-exchange displacement chromatography for the purification of recombinant protein therapeutics from variants. J. Biotechnol., 1998, 66, (2–3), 125–136.
- 186 Natarajan, V., Ghose, S., Cramer, S.M.: Comparison of linear gradient and displacement separations in ion-exchange systems. Biotechnol. Bioeng., 2002, 78, 365–375.
- 187 Ladisch, M.R., Kohlmann, K.L.: . Biotechnol. Prog., 1992, 8, (6) 469–478.
- 188 Lu, P., Carr, D., Chadwick, P., Li, M., Harrison, K.: Process purification of polypeptides and proteins by reversed-phase column chromatography. BioPharm, 2001, 9, 28–35.
- 189 Ghose, S., McNerney, T.M., Hubbard, B.: Preparative protein purification on underivatized silica. Biotechnol. Bioeng., 2004, 87, (3), 413–423.
- 190 Kelley, B.D., Tannatt, M., Magnusson, R., Hagelberg, S., Booth, J.: Development and validation of an affinity chromatography step using a peptide ligand for cGMP production of Factor VIII. Biotechnol. Bioeng., 2004, 87, (3), 400–412.
- 191 Montagna, J.M., Pinto, J.M., Asenjo, J.A.: Optimal design of protein production plants with time and size factor process models. Biotechnol. Prog., 2000, 16, 228–237.
- 192 Frey, D.D., Kang, X.: New concepts in the chromatography of peptides and proteins. Curr. Opin. Biotechnol., 2005, 16, 552–560.
- 193 Morrill, P.R., Gupta, G., Sproule, K., Winzor, D., Christensen, J., Mollerup, I., Lowe, C.R.: Rational combinatorial chemistry-based selection, synthesis and evaluation of an affinity adsorbent for recombinant human clotting factor VII. J. Chromatogr. B, 2002, 774, 1–15.
- 194 Sproule, K., Morrill, P., Pearson, J.C., Burton, S.J., Hejnaes, K.R., Valore, H., Ludvigsen, S., Lowe, D.: New strategy for the design of ligands for the purification of pharmaceutical proteins by affinity chromatography. J. Chromatogr. B, 2000, 740, 17–33.
- 195 Necina, R., Amatschek, K., Schallaun, E., Schwinn, H., Josic, D., Jungbauer, A.: Peptide affinity chromatography of human clotting factor VIII. Screening of the vWF-binding domain. J. Chromatogr. B, 1998, 715, (1), 191–201.
- 196 Pflegerl, K., Hahn, R., Berger, E., Jungbauer, A., Mutational analysis of a blood coagulation factor VIII-binding peptide. J. Peptide Res., 2002, 59, 174–182.
- 197 Kaufman, D.B., Hentsch, M.E., Baumbach, G.A., Buettner, J.A., Dadd, C.A., Huang, P.Y., Hammond, D.J., Carbonell, R.G.: Affinity purification of fibrinogen using a ligand from a peptide library. Biotechnol. Bioeng., 2002, 77, 278–289.
- 198 Roque, A.C.A., Lowe, C.R., Taipa, M.A.: Antibodies and genetically engineered related molecules: production and purification. Biotechnol. Prog., 2004, 20, 639–654.
- 199 Vlakh, E., Ostryanina, N., Jungbauer, A., Tennikova, T.: Use of monolithic sorbents modified by directly synthesized peptides for affinity separation of recombinant tissue plasminogen activator (t-PA). J. Biotechnol., 2004, 107, 275–284.
- 200 Swaminathan, S., Khanna, N.: Affinity purification of recombinant Interferon-α on a mimetic ligand adsorbent. Prot. Expr. Purif., 1999, 15, 236–242.
- 201 Kabir, S.: Immunoglobulin purification by affinity chromatography using protein A mimetic ligands prepared by combinatorial chemical synthesis. Immunol. Invest., 2002, 31, (3–4), 263–278.
- 202 Fassina, G., Ruvo, M., Palombo, G., Verdoliva, A., Marino, M.: Novel ligands for the affinity-chromatographic purification of antibodies. J. Biochem. Biophys. Methods, 2001, 49, 481–490.
- 203 Rönnmark, J., Grönlund, H., Uhlén, M., Nygren, P.A.: Human immunoglobulin A (IgA)-specific ligands from combinatorial engineering of protein A. Eur. J. Biochem., 2002, 269, 2647–2655.
- 204 Ghose, S., Hubbard, B., Cramer, S.M.: Protein interactions in hydrophobic charge induction chromatography (HCIC). Biotechnol. Prog., 2005, 21, 498–508.
- 205 Weatherly, G.T., Bouvier, A., Lydiard, D.D., Chapline, J., Henderson, I., Schrimsher, J.L., Shepard, S.R.: Initial purification of recombinant botulinum neurotoxin fragments for pharmaceutical production using hydrophobic charge induction chromatography. J. Chromatogr. A, 2002, 952, 99–110.
- 206 Mao, Q.M., Prince, I.G., Hearn, M.T.W.: High-performance liquid chromatography of amino acids, peptides and proteins CXXXIX. Impact of operating parameters in large-scale chromatography of proteins. J. Chromatogr. A, 1995, 691, 273–283.
- 207 Ghose, S., Cramer, S.: Characterization and modeling of monolithic stationary phases: application to preparative chromatography. J. Chromatogr. A, 2001, 928, 13–23.
- 208 Lienqueo, M.E., Mahn, A., Asenjo, J.A.: Mathematical correlations for predicting protein retention times in hydrophobic interaction chromatography. J. Chromatogr. A, 2002, 978, 71–79.
- 209 Xia, F., Nagrath, D., Cramer, S.M.: Modeling of adsorption in hydrophobic interaction chromatography systems using a preferential interaction quadratic isotherm. J. Chromatogr. A, 2003, 989, 47–5.
- 210 Wiesel, A., Schmidt-Traub, H., Lenz, J., Strube, J.: Modelling gradient elution of bioactive multicomponent systems in non-linear ion-exchange chromatography. J. Chromatogr. A, 2003, 1006, 101–120.
- 211 Karlsson, D., Jakobsson, N., Brink, K.L., Axelsson, A., Nilsson, B.: Methodologies for model calibration to assist the design of a preparative ion-exchange step for antibody purification. J. Chromatogr. A, 2004, 1033, (1), 71–82.
- 212 Natarajan, V., Purdom, G.: Advances in process chromatography gradient elution using binary linear gradients. J. Chromatogr. A, 2001, 908, 163–167.
- 213 Williams, A., Taylor, K., Dambuleff, K., Persson, O., Kennedy, R.M.: Maintenance of column performance at scale. J. Chromatogr. A, 2002, 944, 69–75.
- 214 Gebauer, K.H., Luo, X.L., Barton, N.G., Stokes, A.N.: Efficiency of preparative and process column distribution systems. J. Chromatogr. A, 2003, 1006, 45–60.
- 215 Hofmann,, M.: Use of ultrasound to monitor the packing of large-scale columns, the monitoring of media compression and the passage of molecules, such as monoclonal antibodies, through the column bed during chromatography. J. Chromatogr. A, 2003, 989, 79–94.
- 216 Willoughby, N., Habib, G., Hoare, M., Hjorth, R., Titchener-Hooker, N.J.: The use of rapid on-line monitoring of products and contaminants from within an expanded bed to control separations exhibiting fast breakthrough characteristics and to maximize productivity. Biotechnol. Bioeng., 2000, 70, (3), 254–261.
- 217 Iberer, G., Schwinn, H., Josic, D., Jungbauer, A., Buchacher, A.: Continuous purification of a clotting factor IX concentrate and continuous regeneration by preparative annular chromatography. J. Chromatogr. A, 2002, 972, (1), 115–129.
- 218 Vogel, J.H., Nguyen, H., Pritschet, M., Van Wegen, R., Konstantinov, K.: Continuous annular chromatography: general characterization and application for the isolation of recombinant protein drugs.. Biotechnol. Bioeng., 2002, 80, (5), 559–568.
- 219 Schlegl, R., Iberer, G., Machold, C., Necina, R., Jungbauer, A.: Continuous matrix-assisted refolding of proteins. J. Chromatogr. A, 2003, 1009, (1–2), 119–32.
- 220 Imamoglu, S.: Simulated moving bed chromatography (SMB) for application in bioseparation. Adv. Biochem. Eng. Biotechnol., 2002, 76, 211–231.
- 221 Paredes, G., Mazzotti, M., Stadler, J., Simulated moving bed technology for bioseparations. Oral presentation at the 12th European Congress on Biotechnology in Copenhagen, Aug 21–24, 2005.
- 222 Hart, R.A., Ogez, J.R., Builder, S.E.: Use of multifactorial analysis to develop aqueous two-phase systems for isolation of non-native IGF-I. Bioseparation, 1995, 5, 113–121.
- 223 Cunha, T., Aires-Barros, R.: Large-scale extraction of proteins. Mol. Biotechnol., 2002, 20, (1), 29–40.
- 224 Andrews, B.A., Schmidt, A.S., Asenjo, J.A.: Correlation for the partition behaviour of proteins in aqueous two-phase systems: effect of surface hydrophobicity and charge. Biotechnol. Bioeng., 2005, 90, (3), 380–390.
- 225 Fairlie, W.D., Uboldi, A.D., De Souza, D.P., Hemmings, G.J., Nicola, N.A., Baca, M.: A fusion protein system for the recombinant production of short disulfide-containing peptides. Prot. Expr. Purif., 2002, 26, 171–178.
- 226 Skosyrev, B., Kulesskiy, C., Yakhnin, D., Temirov, W., Vinokurov, D.: Expression of the antibacterial peptide sarcotoxin IA in Escherichia coli cells. Protein Expr. Purif., 2003, 28, 350–356.
- 227 Metlitskaia, L., Cabralda, J.E., Suleman, D., Kerry, C. et al., Recombinant antimicrobial peptides efficiently produced using novel cloning and purification processes. Biotechnol. Appl. Biochem., 2004, 39, (3), 339–345.
- 228 Wood, D.W., Wu, W., Belfort, G., Derbyshire, V., Belfort, M.: A genetic system yields self-cleaving inteins for bioseparations. Nat. Biotechnol., 1999, 17, 889–892.
- 229 Wood, D.W., Derbyshire, V., Wu, W., Chartrain, M., Belfort, M., Belfort, G.: Optimized single-step affinity purification with a self-cleaving intein applied to human acidic fibroblast growth factor. Biotechnol. Prog., 2000, 16, 1055–1063.
- 230 Sharma, S., Zhang, A., Wang, H., Harcum, S.W., Chong, S., Study of protein splicing and intein-mediated peptide bond cleavage under high-cell-density conditions. Biotechnol. Prog., 2003, 19, 1085–1090.
- 231 Chong, S., Mersha, F.B., Comb, D.G., Scott, M.E. et al., Single-column purification of free recombinant proteins using self-cleavable affinity tag derived from a protein splicing element. Gene, 1997, 192, (2), 271–281.
- 232 Sun, Z., Chen, J., Yao, H., Liu, L., Wang, J., Zhang, J., Liu, J.N.: Use of Ssp dnaB derived mini-intein as a fusion partner for production of recombinant human brain natriuretic peptide in Escherichia coli. Protein Expr. Purif., 2005, 43, 26–32.
- 233 Barnard, G.C., McCool, J.D., Wood, D.W., Gerngross, T.U.: Integrated recombinant protein expression and purification platform based on Ralstonia eutropha. Appl. Environ. Microbiol., 2005, 71, (10), 5735–5742.
- 234 Pezza, J.A., Allen, K.N., Tolan, D.R.: Intein-mediated purification of a recombinantly expressed peptide. Chem. Commun., 2004, 2412–2413.
- 235 Zhang, A., Gonzalez, S.M., Cantor, E.J., Chong, S.: Construction of a mini-intein fusion system to allow both direct monitoring of soluble protein expression and rapid purification of target proteins. Gene, 2001, 275, 241–252.
- 236 Reed, D.C., Barnard, G.C., Anderson, E.B., Klein, L.T., Gerngross, T.U., Production and purification of self-assembling peptides in Ralstonia eutropha. Protein Expr. Purif. doi:10.1016/j.pep.2005.08.023.
- 237 Kaar, W., Greinstetter, S., Wechner, P., Achmüller, C., Auer, B., Clementschitsch, F., Bayer, K., Jungbauer, A., Refolding of autoprotease fusion proteins. Poster presented at the 25th ISPPP, November 6–10, 2005 in St. Pete Beach (FL, USA).
- 238 Maharbiz, M.M., Holtz, W.J., Howe, R.T., Keasling, J.D.: Microbioreactor arrays with parametric control for high-throughput experimentation. Biotechnol. Bioeng., 2004, 85, (4), 376–381.
- 239 Preston, N.S., Baker, D.J., Bottomley, S.P., Gore, M.G.: The production and characterisation of an immobilized chaperonin system. Biochim. Biophys. Acta, 1999, 1426, 99–109.
- 240 Maskos, K., Huber-Wunderlich, M., Glockshuber, R.: DsbA and DsbC-catalyzed oxidative folding of proteins with complex disulfide bridge patterns in vitro and in vivo. J. Mol. Biol., 2003, 325, 495–513.
- 241 Kohler, R.J., Preuss, M., Miller, A.D.: Design of a molecular chaperone-assisted protein folding bioreactor. Biotechnol. Prog., 2000, 16, 671–675.
- 242 Li, J., Wang, S., Van Dusen, W.J., Schultz, L.D. et al., Design of a molecular chaperone-assisted protein folding bioreactor. Biotechnol. Prog., 2000, 16, 671–675.
- 243 Willoughby, D., Martin, W., Titchener-Hooker, D.: Extreme scale-down of expanded bed adsorption: Purification of an antibody fragment directly from recombinant E. coli culture. Biotechnol. Bioeng., 2004, 87, (5), 641–647.
- 244 Rathore, A.S., Krishnan, R., Tozer, S., Smiley, D., Rausch, S., Seely, J.: Scaling down of biopharmaceutical unit operations – part 2: chromatography and filtration. BioPharm., 2005, 4, 58–64.
- 245 Shukla, A.A., Sorge, L., Boldman, J., Waugh, S.: Process characterization for metal-affinity chromatography of an Fc fusion protein: a design-of-experiments approach. Biotechnol. Appl. Biochem., 2001, 34, (2), 71–80.
- 246 Novais, J.L., Titchener-Hooker, N.J., Hoare, M.: Economic comparison between conventional and disposable-based technology for the production of biopharmaceuticals. Biotechnol. Bioeng., 2001, 75, 143–153.
- 247 Eaton,, L.C.: Host cell protein assay development for recombinant pharmaceuticals. J. Chromatogr. A, 1995, 705, (1), 105–114.
- 248 Rathore, A., Sobacke, B., Kocot, C., Morgan, D., Dufield, W., Mozier, D.: Analysis for residual host cell proteins and DNA in process streams of a recombinant protein product expressed in Escherichia coli cells. J. Pharm. Biomed. Anal., 2003, 32, 1199–1211.
- 249 Lovatt, A.: Applications of quantitative PCR in the biosafety and genetic stability assessment of biotechnology products. Review Mol. Biotech., 2002, 82, 279–300.
- 250 Montaser, A., Inductively Coupled Plasmas in Analytical Atomic Spectrometry, 2nd ed., 1998, Wiley-VCH, New York.
- 251 PDA Technical Report No. 33, Evaluation, Validation and Implementation of New Microbiological Testing Methods. PDA J. Pharm. Sci. Technol., 2000, 54, (3), Suppl. TR33, 1–37.
- 252 Olson, K.C., Gehant, R.L.: Applications of ultrafast HPLC to process development of recombinant DNA-derived proteins. Biotechnol. Prog., 1992, 8, 562–566.
- 253 O'Keefe, D.D., Duke, G.J.: Fast quantitation of recombinant plasminogen activator inhibitor type 1 in bacterial lysates by micropellicular reversed-phase liquid chromatography. J. Chromatogr. A., 2000, 891, 85–92.
- 254 Feng, B., Patel, A.H., Keller, P.M., Slemmon, J.R.: Fast characterization of intact proteins using a high-throughput eight-channel parallel liquid chromatography/mass spectrometry system. Rapid Commun. Mass Spectrom., 2001, 15, 821–816.
- 255 Premstaller, A., Oefner, P.J., Oberacher, H., Huber, C.G.: Capillary array high-performance liquid chromatography of nucleic acids and proteins. Anal. Chem., 2002, 74, 4688–4693.
- 256 Baker, K.N., Rendall, M.H., Patel,, A., Boyd, P., Hoare, M. et al., Rapid monitoring of recombinant protein products: a comparison of current technologies. Trends Biotechnol., 2002, 20, 149–156.
- 257 Peuker, T., Riedel, M., Kaiser, C., Ellert, A., Lenz, K., Elsholz, O., Luttmann, R.: At-line determination of glucose, ammonia, and acetate in high cell density cultivations of Escherichia coli. Eng. Life Sci., 2004, 4, 138–143.
- 258 Forrer, K., Hammer, S., Helk, B.: Chip-based gel electrophoresis method for the quantification of half-antibody species in IgG4 and their by- and degradation products. Anal. Biochem., 2004, 334, 81–88.
- 259 Vasilyeva, E., Woodard, J., Taylor, F.R., Kretschmer, M., Fajardo, H. et al., Development of a chip-based capillary gel electrophoresis method for quantification of a half-antibody in immunoglobulin G4 samples. Electrophoresis, 2004, 25, 3890–3896.
- 260 Apffel, A., Chakel, J., Udiavar, S., Swedberg, S., Hancock, W.S. et al., Application of new analytical technology to the production of a “well-characterized biological”. Dev. Biol. Stand., 1998, 96, 11–25.
- 261 Wuhrer, M., Deelder, A.M., Hokke, C.H.: Protein glycosylation analysis by liquid chromatography-mass spectrometry. J. Chromatogr. B, 2005, 825, 124–133.
- 262 Premstaller, A., Oberacher, H., Walcher, W., Timperio, A.M., Zolla, L. et al., High-performance liquid chromatography-electrospray ionization mass spectrometry using monolithic capillary columns for proteomic studies. Anal. Chem., 2001, 73, 2390–2396.
- 263 Novotny, M.V., Mechref, Y.: New hyphenated methodologies in high-sensitivity glycoprotein analysis. J. Sep. Sci., 2005, 28, 1956–1968.
- 264 Patrick, J.S., Lagu, A.L.: Review applications of capillary electrophoresis to the analysis of biotechnology-derived therapeutic proteins. Electrophoresis, 2001, 22, 4179–4196.
- 265 Kakehi, K., Kinoshita, M., Nakano, M.: Analysis of glycoproteins and the oligosaccharides thereof by high-performance capillary electrophoresis – significance in regulatory studies on biopharmaceutical products. Biomed. Chromatogr., 2002, 16, 103–15.
- 266 Fenn, J.B., Mann, M., Meng, C.K., Wong, S.F., Whitehouse, C.M.: Electrospray ionization for mass spectrometry of large biomolecules. Science, 1989, 246, 64–71.
- 267 Karas, M., Bachmann, D., Bahr, U., Hillenkamp, F.: Matrix-assisted ultraviolet laser desorption of non-volatile compounds. Int. J. Mass Spectrom. Ion Proc., 1987, 78, 53–68.
- 268 Tanaka, K., Waki, H., Ido, Y., Akita, S., Yoshida, Y., Yoshida, T.: Protein and polymer analyses up to m/z 100 000 by laser ionization time-of-flight mass spectrometry. Rapid Commun. Mass Spectrom., 1988, 2, 151–153.
- 269 Cristoni, S., Rossi, B.L.: Development of new methodologies for the mass spectrometry study of bioorganic macromolecules. Mass Spec. Rev., 2003, 22, 369–406.
- 270 Le, J.C., Bondarenko, P.V.: Trap for MAbs: Characterization of intact monoclonal antibodies using reversed-phase HPLC on-line with ion-trap mass spectrometry. J. Am. Soc. Mass Spectrom., 2005, 16, 307–311.
- 271 Lyubarskaya, Y., Houde, D., Woodard, J., Murphy, D., Mhatre, R.: Analysis of recombinant monoclonal antibody isoforms by electrospray ionization mass spectrometry as a strategy for streamlining characterization of recombinant monoclonal antibody charge heterogeneity. Anal. Biochem., 2006, 348, 24–39.
- 272 Ling, V.T., Guzzetta, A.W., Canova-Davis, E., Stults, J.T., Hancock, W.S. et al., Characterization of the tryptic map of recombinant DNA derived tissue plasminogen activator by high-performance liquid chromatography-electrospray ionization mass spectrometry. Anal. Chem., 1991, 63, 2909–2915.
- 273 Henzel, W.J., Billeci, T.M., Stults, J.T., Wong, S.C., Grimley, C., Watanabe, C.: Identifying proteins from two-dimensional gels by molecular mass searching of peptide fragments in protein sequence databases. Proc. Natl. Acad. Sci. USA, 1993, 90, 5011–5015.
- 274 Yates, J.R. III, Speicher, S., Griffin, P.R.: Hunkapiller, T., Peptide mass maps: A highly informative approach to protein identification. Anal. Biochem., 1993, 214, 397–408.
- 275 Harris, B., Kabakoff, C., Macchi, D., Shen, W., Kwong, D. et al., Identification of multiple sources of charge heterogeneity in a recombinant antibody. J. Chromatogr. B, 2001, 752, 233–245.
- 276 Zhang, W., Marzilli, L.A., Rouse, J.C., Czupryn, M.J.: Complete disulfide bond assignment of a recombinant immunoglobulin G4 monoclonal antibody. Anal. Biochem., 2002, 311, 1–9.
- 277 Dancik, B., Addona, C., Clauser, D., Vath, W., Pevzner, D.: De novo peptide sequencing via tandem mass spectrometry. J. Comput. Biol., 1999, 6, 327–342.
- 278 Taylor, J.A., Johnson, R.S.: Implementation and uses of automated de novo peptide sequencing by tandem mass spectrometry. Anal. Chem., 2001, 73, 2594–2604.
- 279 Zaia, J.: Mass spectrometry of oligosaccharides. Mass Spec. Rev., 2004, 23, 161–227.
- 280 Goetz, H., Kuschel, M., Wulff, T., Sauber, C., Miller, C. et al., . J. Biochem. Biophys. Methods, 2004, 60, 281–93.
- 281 Wyatt, P.J.: Light scatterering and the absolute characterization of macromolecules. Anal. Chim. Acta, 1993, 272, 1–40.
- 282 Wen, J., Arakawa, T., Philo, J.S.: Size-exclusion chromatography with on-line light-scattering, absorbance, and refractive index detectors for studying proteins and their interactions. Anal. Biochem., 1996, 240, 155–66.
- 283 Kolvenbach, C., Narhi, D., Philo, W., Li,, D. et al., Granulocyte-colony stimulating factor maintains a thermally stable, compact, partially folded structure at pH 2. J. Peptide Res., 1997, 50, 310–318.
- 284 Lebowitz, J., Lewis, M.S., Schuck, P.: . Protein Sci., 2002, 11, 2067–2079.
- 285 Fraunhofer, W., Winter, G.: The use of asymmetrical flow field-flow fractionation in pharmaceutics and biopharmaceutics. Eur. J. Pharm. Biopharm., 2004, 58, 369–383.
- 286 Albrecht, H., Burke, P.A., Natarajan, A., Xiong, C.Y., Kalicinsky, M., DeNardo, G.L., DeNardo, S.: Production of soluble ScFvs with C-terminal-free thiol for site-specific conjugation or stable dimeric ScFvs on demand. Bioconj. Chem., 2004, 15, 16–26.
- 287 Wahlberg, E., Lendel, C., Helgstrand, M., Allard, P. et al., An affibody in complex with a target protein: structure and coupled folding. Proc. Natl. Acad. Sci. USA, 2003, 100, (6), 3185–3190.
- 288 Fernandez, L.A.: Prokaryotic expression of antibodies and affibodies. Curr. Opin. Biotechnol., 2004, 15, 364–373.
- 289 Szymanski, C.M., Wren, B.W.: Protein glycosylation in bacterial mucosal pathogens. Nat. Rev. Microbiol., 2005, 3, 225–237.
- 290 Feng, W., Cai, J., Pierce, W.P. Jr., Song, Z.H.: Expression of CB2 cannabinoid receptor in Pichia pastoris. Protein Expr. Purif., 2002, 26, 496–505.
- 291 Bisht, H., Chugh, D.A., Raje, M., Swaminathan, S., Khanna, N.: Recombinant dengue virus type 2 envelope/hepatitis B surface antigen hybrid protein expressed in Pichia pastoris can function as a bivalent immunogen. J. Biotechnol., 2002, 99, 97–110.
- 292 Lee, J., Choi, S.I., Jang, J.S., Jang, K., Moon, J.W., Bae, C.S., Yang, D.S., Seong, B.L.: Novel secretion system of recombinant Saccharomyces cerevisiae using an N-terminus residue of human IL-1β as secretion enhancer. Biotechnol. Prog., 1999, 15, 884–890.
- 293 Bae, C.S., Yang, D.S., Lee, J., Park, Y.H.: Improved process for production of recombinant yeast-derived monomeric human G-CSF. Appl. Microbiol. Biotechnol., 1999, 52, (3), 338–344.
- 294 Yadava, A., Ockenhouse, C.F.: Effect of codon optimization on expression levels of a functionally folded malaria vaccine candidate in prokaryotic and eukaryotic expression systems. Infect. Immun., 2003, 71, (9), 4961–4969.
- 295 Avgerinos, G.C., Turner, B.G., Gorelick, K.J., Papendieck, A., Weydemann, U., Gellissen, G.: Production and clinical development of a Hansenula polymorpha – derived PEGylated hirudin. Semin. Thromb. Hemost., 2001, 27, 357–371.
Citing Literature
